Your trusted destination for CME, CPD & Medical Education across the Middle East.
ICPACT-26 offers an educational platform covering current developments in pathology, laboratory diagnostics, clinical research, and clinical trial practices. The program provides participants with insights into emerging diagnostic technologies, biomarkers, translational research, trial methodologies, and innovations supporting evidence-based healthcare.
The International Conference on Pathology and Clinical Trials (ICPACT-26) provides a multidisciplinary platform for pathologists, laboratory professionals, clinicians, researchers, clinical trial specialists, and healthcare experts to explore advances in pathology and clinical research. The conference focuses on emerging diagnostic approaches, disease mechanisms, laboratory technologies, and developments in the design and conduct of clinical trials. Key topics may include molecular pathology, histopathology, diagnostic biomarkers, precision medicine, translational research, clinical trial methodologies, and patient-centered research. Participants will have opportunities to exchange research findings, discuss clinical experiences, and examine innovations that support accurate diagnosis and the development of new medical interventions. The scientific program encourages collaboration among healthcare institutions, academic organizations, research centers, pharmaceutical and biotechnology stakeholders, and clinical research professionals. Through expert presentations, scientific sessions, and interactive discussions, ICPACT-26 supports knowledge exchange and continued advancement in pathology and clinical research.
Latest techniques and advancements in histopathology and cytopathology.
Advances in molecular diagnostics, genomics, and companion diagnostics.
Utilization of new biomarkers and diagnostic technologies for disease detection and monitoring.
How pathology contributes to clinical trials from initial design to patient selection.
Current methodologies, research findings, and emerging developments in drug development.
Navigating the regulatory, ethical, and quality considerations surrounding pathology specimens.
Applications of AI and image analysis in pathology diagnosis and research.
Integration of pathology data with clinical, genomic, and laboratory information.
Best practices for tissue collection, processing, storage, and biobanking.
Ensuring standardization, validation, quality control, and reproducibility of pathology-based testing.
Pathology approaches for cancer diagnosis and tumor classification.
Evaluating treatment responses and their impact on clinical decision-making.
Approaches for converting laboratory discoveries into clinical applications.
Accredited by the Saudi Commission for Health Specialties (SCFHS) for 6 CME hours.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow